These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28073646)

  • 1. Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
    Segura-Villalobos F; Hernández-Guerra AI; Wanguemert-Pérez F; Rodríguez-Pérez JC; Mendoza-Lemes H; Barriales-Villa R
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):604-606. PubMed ID: 28073646
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 3. A lethal pedigree of hypertrophic cardiomyopathy associated with mild left ventricular hypertrophy.
    Watson P; Burstow D; Stafford W
    Aust N Z J Med; 1996 Dec; 26(6):845-6. PubMed ID: 9028521
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.
    Hecht GM; Klues HG; Roberts WC; Maron BJ
    J Am Coll Cardiol; 1993 Aug; 22(2):489-97. PubMed ID: 8335819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy: case report.
    Mukhtar AU; Ihunwo AO
    East Afr Med J; 1999 Sep; 76(9):535-6. PubMed ID: 10685328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathology of hypertrophic cardiomyopathy.
    Hughes SE
    Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy and arrhythmogenic right ventricular dysplasia in young patients.
    Frias PA
    Semin Pediatr Neurol; 2005 Mar; 12(1):25-31. PubMed ID: 15929462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.
    Varnava AM; Elliott PM; Baboonian C; Davison F; Davies MJ; McKenna WJ
    Circulation; 2001 Sep; 104(12):1380-4. PubMed ID: 11560853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 11. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass.
    Maron BJ; Kragel AH; Roberts WC
    Br Heart J; 1990 May; 63(5):308-10. PubMed ID: 2278803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening and risk assessment in hypertrophic cardiomyopathy.
    MacRae CA; Ellinor PT
    J Am Coll Cardiol; 2004 Dec; 44(12):2326-8. PubMed ID: 15607393
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 18. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death risk stratification in hypertrophic cardiomyopathy: genetic and clinical bases.
    Piva e Mattos B
    Arq Bras Cardiol; 2006 Sep; 87(3):391-9. PubMed ID: 17057942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sudden unexpected death of cardiac origin in the 6 to 18 years population. Pathologic data. Role of sports? How can we prevent it?].
    Dupuis JM; Tabib A; Reix P; Dupuis L; Daudet G; Jocteur-Monrozier D; Malicier D; Bellon G
    Arch Pediatr; 2005 Aug; 12(8):1204-8. PubMed ID: 16051073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.